• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Screening all donated blood for Zika virus is not cost-effective in the United States

byCaitlyn HuiandDeepti Shroff Karhade
January 8, 2019
in Infectious Disease, Oncology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. This microsimulation study suggested that screening blood for Zika virus is only cost-effective during the high mosquito season in Puerto Rico.

2. The authors of the study did not identify any cost-effective screening policy for Zika virus in the 50 states.

Evidence Rating Level: 2 (Good)

Study Rundown: Zika is an emerging infectious disease that increased in prevalence in the Americas in 2015 with the largest recorded outbreak to date. Considering the significant comorbidities associated with Zika virus infection, including microcephaly in newborns and Guillain-Barre syndrome, it is becoming increasingly important to implement measures of protecting blood transfusion recipients from exposure to Zika virus. In 2016, universal individual donation nucleic acid testing was conducted for donated blood for Zika virus in the United States. The authors of this study evaluated the cost-effectiveness of this universal screening during the first year of the process, compared to alternatives for the 50 states and separately for Puerto Rico. The authors did not find that screening all donated blood for Zika virus in all 50 states was cost-effective. It was only cost effective in Puerto Rico during the season of high mosquito activity. The main study limitation was that long-term sequelae of infection were not evaluated in this study. However, this study does provide insights that should help inform policy decisions and future research.

Click to read the study, published today in Annals of Internal Medicine

Relevant Reading: Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April–August 2016

In-Depth [cost-effectiveness analysis]: The authors conducted a microsimulation study to evaluate the cost-effectiveness of screening all donated blood for Zika virus in the United States. The model utilized the blood center costs, adverse events and lifetime health economic consequences of adverse events due to transfusion of the Zika virus. The authors did not find any cost-effective screening policies in the 50 states during their analysis. Specifically, no intervention was cost-effective in 99.99% of simulation iterations. In contrast, in Puerto Rico, the authors observed that screening during the high mosquito activity season was the most cost-effective in 64% of probabilistic sensitivity analysis iterations. In the case analyses, this was cost effective at $81,123 per QALY (95% CI, -$49,138 to $978,242 per QALY) with mini-pool NAT in high season and no testing in low season. The authors observed that with no transfusion intervention in Puerto Rico, an estimated 242.2 cases (95% CI, 194.9 to 291.5 cases) of transfusion transmission would have occurred during one year. This value contrasted with the 50 states and Washington, DC, where an estimated 44.7 cases (CI, 32.1 to 59.1 cases) of transfusion transmission would have occurred in one year with no intervention.

RELATED REPORTS

Congenital Zika syndrome is associated with higher risk of death

#VisualAbstract ESCORT-HU highlights the real-life positive benefit-to-risk ratio of hydroxyurea in patients with sickle cell disease

#VisualAbstract: Immediate Transfusion in African Children with Uncomplicated Severe Anemia

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: blood transfusionZika virus
Previous Post

The RECIST 1.1 trial: Measuring tumor burden to assess response to therapy [Classics Series]

Next Post

Cardiac troponin elevation without definitive diagnosis associated with higher mortality

RelatedReports

Microcephaly rates elevated in Brazil prior to Zika virus epidemic
Chronic Disease

Congenital Zika syndrome is associated with higher risk of death

March 1, 2022
#VisualAbstract ESCORT-HU highlights the real-life positive benefit-to-risk ratio of hydroxyurea in patients with sickle cell disease
StudyGraphics

#VisualAbstract ESCORT-HU highlights the real-life positive benefit-to-risk ratio of hydroxyurea in patients with sickle cell disease

October 8, 2021
#VisualAbstract: Immediate Transfusion in African Children with Uncomplicated Severe Anemia
StudyGraphics

#VisualAbstract: Immediate Transfusion in African Children with Uncomplicated Severe Anemia

September 4, 2019
Ticagrelor reversal agent provides immediate and sustained effect
Chronic Disease

The TRACT trial: no mortality benefit observed in African children with uncomplicated severe anemia who receive transfusion

August 2, 2019
Next Post
Significant number of wrong-patient errors in radiology reports

Cardiac troponin elevation without definitive diagnosis associated with higher mortality

Risk factors identified for adverse pregnancy outcomes in patients with stable lupus

Maternal obesity linked to increased risk of certain congenital heart defects

Publication of pneumonia antibiotic guidelines changed prescribing trends

Direct-to-consumer medical marketing spending increased over last eighteen years

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Metformin use may decrease risk of osteoarthritis development
  • Intensive blood pressure lowering by non-physician healthcare providers significantly reduces the risk of cardiovascular disease
  • Expectant management of patent ductus arteriosus noninferior to early ibuprofen use
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options